HC Wainwright Reiterates Buy Rating on Sophia Genetics, Sets $14 Target
HC Wainwright reiterated its Buy rating on Sophia Genetics with a $14 price target. The target implies 88.9% upside from the Oct. 9 close of $7.41.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.